News
Volatility and volume drive market makers profits, which are being aggressively returned to shareholders
Every second week we invite a leading fund manager to present at The Insider: Meet the Fund Manager. In October, East 72’s Andrew Brown selected Vivendi (EPA: VIV) as one of his favourite stocks, sharing some of his thoughts on…
Note from MD: Interest rates and rare earth restrictions both rise
Another rate rise by the RBA on Melbourne Cup Day which took the cash rate target to 4.35% saw the Australian dollar and bond yields tumble. Investors were wrong-footed by the RBA’s softer-than-expected stance, as it signalled that while it would be willing to hike further if required, it is reluctant to do so unless absolutely necessary.
Pre-Christmas Retail Spending Up in 2023, Estimates Suggest
The two months leading up to Christmas are often critical for Australia’s retail sector, and this year is no different, with pre-Christmas spending in 2023 tipped to edge in line with last year’s results.
U.S. Restaurant charges extra for ‘adults unable to parent’
We’ve all seen questionably behaved kids at restaurants before, but this U.S. eatery has taken things a step further than most.
French conglomerate has a knack for acquiring, building and selling
Every second week we invite a leading fund manager to present at The Insider: Meet the Fund Manager. In October, East 72’s Andrew Brown selected Vivendi (EPA: VIV) as one of his favourite stocks, sharing some of his thoughts on…
Note from MD: Tech acquisitions fly as Fed expected to pause rates
Wall Street had a decent night in the lead up to the Fed’s interest rate decision, as some more economic data came in largely in line with expectations, spurring hope of the Fed holding its monetary policy again for the time being.
Market correction shows uncertainty in global economy
The global share markets appear to be correcting as the ASX on Monday dropped below the one-year lows briefly touched last week, closing 54.5 points, or 0.8%, lower at 6772.9.
All the different wonderful rare earth elements
In light of the strong long term outlook on rare earth elements due to their critical position in the green transition, Reach Markets have written a Rare Earths Explained review. This industry review delves into what rare earths are, where they come from, their place in net zero ambitions and geopolitics, key ESG considerations and supply/demand factors.
Prescient Therapeutics: cashed up with encouraging results flowing
Prescient Therapeutics (ASX: PTX) reported encouraging results in several key targeted and cell therapies in its September quarter activities report.
Traffic Technologies releases its September quarterly activity report
Traffic Technologies Ltd (ASX: TTI) has released its September quarterly activity report, in which they highlight a solid outlook going forward.
Albanese discusses key AUKUS legislation with U.S. President Biden
Prime Minister Anthony Albanese has arrived in the U.S. to discuss a number of key touchpoints with President Joe Biden, the visit is set to stretch out over four days.
Specialist healthcare fundie pounces on later stage novel technologies
In the lead up to this week’s The Insider: Meet the Fund Manager, Matt McNamara from Horizon 3 Healthcare sat down with Reach Markets to provide a bit of information about his investment strategy and the novel technologies that he is most interested in.
Connecting quality investors and innovative companies to facilitate mutual wealth creation with trust and transparency
Receive the latest news and media directly to your inbox
By clicking submit, I agree to the terms of the Reach Markets Financial Services Guide that includes the Privacy Statement.